| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/14/2008 | US20080039397 Polynucleotide encoding a tropoelastin polypeptide; expression products and hybrid molecules of the derivatives and variants |
| 02/14/2008 | US20080039393 Metal-binding therapeutic peptides |
| 02/14/2008 | US20080039338 Human antibodies as detection reagents |
| 02/14/2008 | US20080039323 Nucleic acid molecule having promoter activity; expressing herbicide tolerance gene in plants |
| 02/14/2008 | US20080038824 Composition and Method for Elevating Gene Transfer Efficiency |
| 02/14/2008 | US20080038748 Antibodies That Recognize Cutting Edge Within The Tgf-Beta Activation Controlling Region |
| 02/14/2008 | US20080038741 T1R taste receptors and genes encoding same |
| 02/14/2008 | US20080038735 Tus DNA binding domains |
| 02/14/2008 | US20080038731 Diagnostics and therapeutic uses of topors |
| 02/14/2008 | US20080038365 TRPC6 involved in glomerulonephritis |
| 02/14/2008 | US20080038287 Method For Identification, Isolation and Production of Antigens to a Specific Pathogen |
| 02/14/2008 | US20080038280 A32 Monoclonal Antibody Fusion Proteins For Use As Hiv Inhibitors And Vaccines |
| 02/14/2008 | US20080038279 Composition For Treating Pathology Associated With Msrv/Herv-W |
| 02/14/2008 | US20080038278 GPAT3 encodes a mammalian, microsomal acyl-coa:glycerol 3- phosphate acyltransferase |
| 02/14/2008 | US20080038273 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection |
| 02/14/2008 | US20080038272 binds highly specifically and/or selectively to human receptors of the Frizzled family; hybridoma cell that produces the antibody |
| 02/14/2008 | US20080038270 Antibody Specific For A Chondroitin Sulphate Epitope |
| 02/14/2008 | US20080038268 Streptococcus Pyogenes Antigens |
| 02/14/2008 | US20080038267 Treatment Of Cancer |
| 02/14/2008 | US20080038266 Antibody or antigen binding fragment that binds acetyl-coA-acetyltransferase of Clostridium difficile |
| 02/14/2008 | US20080038265 Antibodies to Erythropoietin Receptor and Uses Thereof |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038262 Using immunoglobulin specific to shiga-like toxin as therapeutic tool in treatment and prevention of enterohemorrhagic escherichia infection |
| 02/14/2008 | US20080038261 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/14/2008 | US20080038260 specifically bind to monocyte-derived dendritic cells (MDDC); immunostimulants; downmodulating transplant rejection; cancer |
| 02/14/2008 | US20080038259 LFA-1 alpaha subunit antibodies and methods of use |
| 02/14/2008 | US20080038258 Polypeptides with Reduced Susceptibility to Oxidation and Methods of Making |
| 02/14/2008 | US20080038257 Hepatocyte growth factor (hgf) binding proteins |
| 02/14/2008 | US20080038256 having the equal or greater binding activity than that of the parent antibody with reduced immunogenicity in human; HGF/SF (hepatocyte growth factor/scatter factor); cancer |
| 02/14/2008 | US20080038255 Splice Variant of Unc5h2 |
| 02/14/2008 | US20080038254 Monoclonal antibody secific to lymphocyte peripheral membrane protein for treating and preventing transplant rejection, blood, skin, autoimmune, allergic and diabetic disorders |
| 02/14/2008 | US20080038253 Methods For Altering T Cell Diversity |
| 02/14/2008 | US20080038250 Profilin and related immunomodulatory ligands |
| 02/14/2008 | US20080038248 Proteins Ligands For Nkg2d And Ul16 Receptors And Uses Thereof |
| 02/14/2008 | US20080038223 WSX-1/P28 as a target for anti-inflammatory responses |
| 02/14/2008 | US20080038205 Novel dermatophagoides proteins |
| 02/14/2008 | US20080038193 Antibodies for use in targeted and temporary treatment of humans and animals |
| 02/14/2008 | US20080038191 Radiolabeled Compounds And Compositions, Their Precursors And Methods For Their Production |
| 02/14/2008 | CA2660584A1 Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof |
| 02/14/2008 | CA2660330A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | CA2659820A1 Ephb3-specific antibody and uses thereof |
| 02/14/2008 | CA2659631A1 Antibodies to erbb2 |
| 02/14/2008 | CA2657763A1 Anti-il-6 monoclonal antibodies and uses thereof |
| 02/14/2008 | CA2656222A1 Fc.gamma.riib-specific antibodies and methods of use thereof |
| 02/13/2008 | EP1887082A2 TADG-15: An extracellular serine protease overexpressed in carcinomas |
| 02/13/2008 | EP1887014A1 Human toll homologues |
| 02/13/2008 | EP1886140A1 Immunological assays and antibodies for anti-mullerian hormone |
| 02/13/2008 | EP1885758A2 Anti-mesothelin antibodies useful for immunological assays |
| 02/13/2008 | EP1885757A2 A method for the production of a monoclonal antibody to cd20 for the treatment of b-cell lymphoma |
| 02/13/2008 | EP1885756A2 Vascular disease therapies |
| 02/13/2008 | EP1885755A2 Anti-cd19 antibody therapy for autoimmune disease |
| 02/13/2008 | EP1885745A2 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 02/13/2008 | EP1885402A2 Antibodies against mammalian metapneumovirus |
| 02/13/2008 | EP1885401A2 Anti-adhesin based passive immunoprophylactic |
| 02/13/2008 | EP1885399A2 Humanized anti-cd40 antibodies and their methods of use |
| 02/13/2008 | EP1885398A1 Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions |
| 02/13/2008 | EP1885397A2 Use of tnf inhibitor for treatment of erosive polyarthritis |
| 02/13/2008 | EP1885388A2 Treating and evaluating inflammatory disorders |
| 02/13/2008 | EP1774331A4 Cytoxan antibodies and immunoassay |
| 02/13/2008 | EP1670350A4 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 02/13/2008 | EP1299420B1 Composition for pharmaceutical and cosmetic products |
| 02/13/2008 | EP1292328B1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor |
| 02/13/2008 | EP1207200B1 High affinity choline transporter |
| 02/13/2008 | EP1124973B1 Antibody-mediated down-regulation of plant proteins |
| 02/13/2008 | EP1005549B1 Prostate tumor polynucleotide and antigen compositions |
| 02/13/2008 | EP0837928B1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 02/13/2008 | EP0820509B1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides |
| 02/13/2008 | EP0770138B1 Mycobacteria functional screening and/or expression vectors |
| 02/13/2008 | CN101124249A Human monoclonal antibodies to prostate specific membrane antigen(PSMA) |
| 02/13/2008 | CN101124248A Binding domain fusion proteins |
| 02/13/2008 | CN101124247A Antibodies directed against amyloid-beta peptide and methods using same |
| 02/13/2008 | CN101124246A Antibodies to angiogenesis inhibiting domains of CD148 |
| 02/13/2008 | CN101124245A Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto |
| 02/13/2008 | CN101124244A Human monoclonal antibodies against CD25 |
| 02/13/2008 | CN101124240A Specific binding agents to hepatocyte growth factor |
| 02/13/2008 | CN101124239A Modulation of ovulation |
| 02/13/2008 | CN101124237A Surface proteins of streptococcus pyogenes |
| 02/13/2008 | CN101123983A Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| 02/13/2008 | CN101123972A Methods for protein production |
| 02/13/2008 | CN101121750A Humanized anti-erbb2 antidbodies and treatment with anti-erbb2 antibodies |
| 02/13/2008 | CN101121749A Gamma-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/13/2008 | CN101121748A Infectivity resistant bursal disease virus VP4 protein monoclonal antibody |
| 02/13/2008 | CN101121021A Humanized anti-ErbB2 antidbodies and treatment with anti-ErbB2 antibodies |
| 02/13/2008 | CN101121020A Anti-gp39 antibodies and its uses |
| 02/13/2008 | CN100368547C Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 02/13/2008 | CN100368546C Food-poisoning fungus concatenated fusion mycinamicin and use thereof |
| 02/13/2008 | CN100368541C Immune magnetic bead negtive-sieve method for sorting cow X sperm based on H-Y antigen |
| 02/12/2008 | US7329745 Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth |
| 02/12/2008 | US7329743 Antigenic peptides are useful as a vaccine |
| 02/12/2008 | US7329739 Useful in recognizing differences in carbohydrates on cell surface (for example, sugar chains and cell surface glycoproteins) reflecting extremely subtle differences among cells, etc. and thus distinguishing, identifying or fractionating various cells |
| 02/12/2008 | US7329738 Assays for detection of Bacillus anthracis |
| 02/12/2008 | US7329737 Human tissue kallikreins; asthma, chronic obstructive pulmonary disease (COPD), multiple sclerosis, psoriasis, rheumatoid arthritis, osteopathic arthritis, osteoarthritis, rhinitis, sinusitus, inflammatory bowel diseases (such as Crohn's disease and ulcerative colitis), immune mediated diabetes |
| 02/12/2008 | US7329729 Secreted epithelial colon stromal-1 molecules and uses thereof |
| 02/12/2008 | US7329639 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; diagnosing and treating cancer; cancer vaccines |
| 02/12/2008 | US7329544 Plant lesion formation suppressing gene, Sp17 and use thereof |
| 02/12/2008 | US7329542 Obtaining a sample from an animal suffering from a cancer, isolating a population of cells, culturing the cells in vitro and harvesting antibodies produced by lymphoids |
| 02/12/2008 | US7329536 Piezoimmunosensor |
| 02/12/2008 | US7329499 Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes |
| 02/12/2008 | US7329496 Sequencing of surface immobilized polymers utilizing microflourescence detection |
| 02/12/2008 | US7329406 Methods of treating psoriasis with αvβ3-specific antibodies |